Limitations, agreements, and source contact

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen · Source last updated 2023-07-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

neuwelte@ohsu.edu

organization

OHSU Knight Cancer Institute

phone

503-494-5626

title

Dr. Edward Neuwelt

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice